Brain Cancer Trial, Recruiting NCT05990244 Sponsor: Shengjing Hospital Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT05990244
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 years of age
  • People who have a relatively good level of physical functioning, as assessed by a standard medical scale called the Karnofsky performance status (score above 60) (confirm with trial site)
  • People who are willing and able to provide written consent to participate
  • People who have had a specific type of brain scan called MRE (Magnetic Resonance Elastography) performed within one week before their surgery
  • People whose tumor measures more than 2 cm in size

Who may not be able to join:

  • People who have previously received any treatment for glioma (a type of brain tumor)
  • People who were unable to complete the MRE scan due to discomfort, such as sensitivity to vibrations or claustrophobia
  • People whose MRE scan results were of poor quality, for example due to movement during the scan or other technical issues
  • People who did not go ahead with surgery after having the MRE scan
  • People whose IDH test results (a laboratory result related to the tumor's biology) are unavailable (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yu Shi, MD, Shengjing Hospital

Phone: +86 189 4025 9980

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shengjing Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2017
Est. completion
1 July 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Surgical assessment of tumor stiffness; Surgical assessment of tumor adhesion; Radiological assessment of tumor stiffness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov